Melissa B Gilkey1, William A Calo2, Jennifer L Moss3, Parth D Shah4, Macary W Marciniak5, Noel T Brewer6. 1. Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, 133 Brookline Ave., Boston, MA 02215, USA. Electronic address: gilkey@unc.edu. 2. Department of Health Policy and Management, University of North Carolina, CB 7411, Chapel Hill, NC 27599, USA. Electronic address: wacalo@live.unc.edu. 3. Department of Health Behavior, University of North Carolina, CB 7440, Chapel Hill, NC 27599, USA. Electronic address: jlmoss@live.unc.edu. 4. Department of Health Behavior, University of North Carolina, CB 7440, Chapel Hill, NC 27599, USA. Electronic address: pdshah@live.unc.edu. 5. Eshelman School of Pharmacy, University of North Carolina, CB 7355, Chapel Hill, NC 27599, USA. Electronic address: macary_marciniak@unc.edu. 6. Department of Health Behavior & Lineberger Comprehensive Cancer Center, University of North Carolina, CB 7440, Chapel Hill, NC 27599, USA. Electronic address: ntb@unc.edu.
Abstract
BACKGROUND: Receiving a healthcare provider's recommendation is a strong predictor of HPV vaccination, but little is known empirically about which types of recommendation are most influential. Thus, we sought to investigate the relationship between recommendation quality and HPV vaccination among U.S. adolescents. METHODS: In 2014, we conducted a national, online survey of 1495 parents of 11-17-year-old adolescents. Parents reported whether providers endorsed HPV vaccination strongly, encouraged same-day vaccination, and discussed cancer prevention. Using an index of these quality indicators, we categorized parents as having received no, low-quality, or high-quality recommendations for HPV vaccination. Separate multivariable logistic regression models assessed associations between recommendation quality and HPV vaccine initiation (≥ 1 dose), follow through (3 doses, among initiators), refusal, and delay. RESULTS: Almost half (48%) of parents reported no provider recommendation for HPV vaccination, while 16% received low-quality recommendations and 36% received high-quality recommendations. Compared to no recommendation, high-quality recommendations were associated with over nine times the odds of HPV vaccine initiation (23% vs. 74%, OR=9.31, 95% CI, 7.10-12.22) and over three times the odds of follow through (17% vs. 44%, OR=3.82, 95% CI, 2.39-6.11). Low-quality recommendations were more modestly associated with initiation (OR=4.13, 95% CI, 2.99-5.70), but not follow through. Parents who received high- versus low-quality recommendations less often reported HPV vaccine refusal or delay. CONCLUSIONS: High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them. Interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
BACKGROUND: Receiving a healthcare provider's recommendation is a strong predictor of HPV vaccination, but little is known empirically about which types of recommendation are most influential. Thus, we sought to investigate the relationship between recommendation quality and HPV vaccination among U.S. adolescents. METHODS: In 2014, we conducted a national, online survey of 1495 parents of 11-17-year-old adolescents. Parents reported whether providers endorsed HPV vaccination strongly, encouraged same-day vaccination, and discussed cancer prevention. Using an index of these quality indicators, we categorized parents as having received no, low-quality, or high-quality recommendations for HPV vaccination. Separate multivariable logistic regression models assessed associations between recommendation quality and HPV vaccine initiation (≥ 1 dose), follow through (3 doses, among initiators), refusal, and delay. RESULTS: Almost half (48%) of parents reported no provider recommendation for HPV vaccination, while 16% received low-quality recommendations and 36% received high-quality recommendations. Compared to no recommendation, high-quality recommendations were associated with over nine times the odds of HPV vaccine initiation (23% vs. 74%, OR=9.31, 95% CI, 7.10-12.22) and over three times the odds of follow through (17% vs. 44%, OR=3.82, 95% CI, 2.39-6.11). Low-quality recommendations were more modestly associated with initiation (OR=4.13, 95% CI, 2.99-5.70), but not follow through. Parents who received high- versus low-quality recommendations less often reported HPV vaccine refusal or delay. CONCLUSIONS: High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them. Interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
Keywords:
Adolescent health; Health communication; Human papillomavirus infections/prevention and control; Human papillomavirus vaccine; Quality of health care
Authors: Paul M Darden; David M Thompson; James R Roberts; Jessica J Hale; Charlene Pope; Monique Naifeh; Robert M Jacobson Journal: Pediatrics Date: 2013-03-18 Impact factor: 7.124
Authors: Paul L Reiter; Kunal Gupta; Noel T Brewer; Melissa B Gilkey; Mira L Katz; Electra D Paskett; Jennifer S Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-03-14 Impact factor: 4.254
Authors: Noel T Brewer; Sami L Gottlieb; Paul L Reiter; Annie-Laurie McRee; Nicole Liddon; Lauri Markowitz; Jennifer S Smith Journal: Sex Transm Dis Date: 2011-03 Impact factor: 2.830
Authors: Rebecca B Perkins; Jack A Clark; Gauri Apte; Jessica L Vercruysse; Justen J Sumner; Constance L Wall-Haas; Anna W Rosenquist; Natalie Pierre-Joseph Journal: Pediatrics Date: 2014-09 Impact factor: 7.124
Authors: Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-22 Impact factor: 4.254
Authors: Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Melissa B Gilkey; Kayoll V Galbraith; Noel T Brewer Journal: Am J Public Health Date: 2013-06-13 Impact factor: 9.308
Authors: Simon R M Dobson; Shelly McNeil; Marc Dionne; Meena Dawar; Gina Ogilvie; Mel Krajden; Chantal Sauvageau; David W Scheifele; Tobias R Kollmann; Scott A Halperin; Joanne M Langley; Julie A Bettinger; Joel Singer; Deborah Money; Dianne Miller; Monika Naus; Fawziah Marra; Eric Young Journal: JAMA Date: 2013-05-01 Impact factor: 56.272
Authors: Laurie D Elam-Evans; David Yankey; Jenny Jeyarajah; James A Singleton; Robinette C Curtis; Jessica MacNeil; Susan Hariri Journal: MMWR Morb Mortal Wkly Rep Date: 2014-07-25 Impact factor: 17.586
Authors: Jocelyn M York; James L Klosky; Yanjun Chen; James A Connelly; Karen Wasilewski-Masker; Anna R Giuliano; Leslie L Robison; F Lennie Wong; Melissa M Hudson; Smita Bhatia; Wendy Landier Journal: J Clin Oncol Date: 2020-06-18 Impact factor: 44.544
Authors: Mary A Gerend; Krystal Madkins; Shariell Crosby; Aaron K Korpak; Gregory L Phillips; Michael Bass; Magda Houlberg; Brian Mustanski Journal: LGBT Health Date: 2019-09-26 Impact factor: 4.151
Authors: Lila J Finney Rutten; Jennifer L St Sauver; Timothy J Beebe; Patrick M Wilson; Debra J Jacobson; Chun Fan; Carmen Radecki Breitkopf; Susan T Vadaparampil; Kathy L MacLaughlin; Robert M Jacobson Journal: Vaccine Date: 2017-09-27 Impact factor: 3.641
Authors: Melissa B Gilkey; Divya Mohan; Ellen M Janssen; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges Journal: Hum Vaccin Immunother Date: 2019-05-07 Impact factor: 3.452
Authors: Teri L Malo; Melissa B Gilkey; Megan E Hall; Parth D Shah; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-10 Impact factor: 4.254
Authors: Melissa B Gilkey; Mo Zhou; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-14 Impact factor: 4.254
Authors: Noel T Brewer; Megan E Hall; Teri L Malo; Melissa B Gilkey; Beth Quinn; Christine Lathren Journal: Pediatrics Date: 2016-12-05 Impact factor: 7.124